{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:12:31Z","timestamp":1778685151716,"version":"3.51.4"},"reference-count":168,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["22213MFDS42 1"],"award-info":[{"award-number":["22213MFDS42 1"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.fct.2024.114636","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T11:36:51Z","timestamp":1712230611000},"page":"114636","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Potential impact of underlying diseases influencing ADME in nonclinical safety assessment"],"prefix":"10.1016","volume":"188","author":[{"given":"Sumin","family":"Cho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harin","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeon Jeong","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changuk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Hyeon","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0155-4190","authenticated-orcid":false,"given":"Jun-Won","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fct.2024.114636_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/9780470942390.mo140195","article-title":"Aging research using mouse models","volume":"5","author":"Ackert-Bicknell","year":"2015","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"10.1016\/j.fct.2024.114636_bib2","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00395-011-0231-7","article-title":"Chronic exercise modulates RAS components and improves balance between pro-and anti-inflammatory cytokines in the brain of SHR","volume":"106","author":"Agarwal","year":"2011","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.fct.2024.114636_bib3","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0140-6736(22)01655-5","article-title":"Type 2 diabetes","volume":"400","author":"Ahmad","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.fct.2024.114636_bib4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.fct.2009.09.030","article-title":"Interaction of nimesulide, a cyclooxygenase-2 inhibitor, with cisplatin in normotensive and spontaneously hypertensive rats","volume":"48","author":"Al Suleimani","year":"2010","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.fct.2024.114636_bib5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet. Med."},{"key":"10.1016\/j.fct.2024.114636_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2016.08.001","article-title":"Drug metabolism in the liver","volume":"21","author":"Almazroo","year":"2017","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.fct.2024.114636_bib7","doi-asserted-by":"crossref","first-page":"e5646","DOI":"10.1590\/1414-431x20165646","article-title":"Non-clinical studies in the process of new drug development - Part II: good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studies","volume":"49","author":"Andrade","year":"2016","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.fct.2024.114636_bib8","first-page":"s176","article-title":"Obesity: definition, comorbidities, causes, and burden","volume":"22","author":"Apovian","year":"2016","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.fct.2024.114636_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104662","article-title":"An FDA\/CDER perspective on nonclinical testing strategies: classical toxicology approaches and new approach methodologies (NAMs)","volume":"114","author":"Avila","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.fct.2024.114636_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41514-021-00076-5","article-title":"Adropin correlates with aging-related neuropathology in humans and improves cognitive function in aging mice","volume":"7","author":"Banerjee","year":"2021","journal-title":"NPJ Aging Mech Dis"},{"key":"10.1016\/j.fct.2024.114636_bib11","first-page":"514","article-title":"Obesity in rhesus and cynomolgus macaques: a comparative review of the condition and its implications for research","volume":"61","author":"Bauer","year":"2011","journal-title":"Comp. Med."},{"key":"10.1016\/j.fct.2024.114636_bib12","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/10837450902891295","article-title":"Drug metabolism and pharmacokinetics","volume":"41","author":"Benedetti","year":"2009","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.fct.2024.114636_bib13","first-page":"442","article-title":"Type 2 diabetes and its impact on the immune system","volume":"16","author":"Berbudi","year":"2020","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.fct.2024.114636_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cotox.2020.02.005","article-title":"Current use of animal models of disease for nonclinical safety testing","volume":"23","author":"Blanset","year":"2020","journal-title":"Current Opinion in Toxicology"},{"key":"10.1016\/j.fct.2024.114636_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097302","article-title":"The db\/db mouse: a useful model for the study of diabetic retinal neurodegeneration","volume":"9","author":"Bogdanov","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.fct.2024.114636_bib16","series-title":"A 2022 Update on the Epidemiology of Obesity and a Call to Action: as its Twin COVID-19 Pandemic Appears to Be Receding, the Obesity and Dysmetabolism Pandemic Continues to Rage on","author":"Boutari","year":"2022"},{"key":"10.1016\/j.fct.2024.114636_bib17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cell.2015.02.022","article-title":"Immune regulation of metabolic homeostasis in health and disease","volume":"161","author":"Brestoff","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.fct.2024.114636_bib18","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1124\/jpet.300.2.460","article-title":"Underlying endotoxemia augments toxic responses to chlorpromazine: is there a relationship to drug idiosyncrasy?","volume":"300","author":"Buchweitz","year":"2002","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.fct.2024.114636_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/138920011794520035","article-title":"Does hepatic steatosis affect drug metabolizing enzymes in the liver?","volume":"12","author":"Buechler","year":"2011","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.fct.2024.114636_bib20","first-page":"H435","article-title":"Myocardial mechanical alterations during gradual onset long-term hypertension in rats","volume":"241","author":"Capasso","year":"1981","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.fct.2024.114636_bib21","series-title":"National Diabetes Statistics Reports","year":"2020"},{"key":"10.1016\/j.fct.2024.114636_bib22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cbi.2012.01.006","article-title":"Modulations of cytochrome P450 expression in diabetic mice by berberine","volume":"196","author":"Chatuphonprasert","year":"2012","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.fct.2024.114636_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1021\/mp700114j","article-title":"Drug-metabolizing enzyme and transporter expression in a mouse model of diabetes and obesity","volume":"5","author":"Cheng","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.fct.2024.114636_bib24","article-title":"Pharmacokinetics, tissue distribution, and excretion characteristics of a radix polygoni multiflori extract in rats","volume":"13","author":"Cheng","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.fct.2024.114636_bib25","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.tiv.2012.06.012","article-title":"Toxicokinetics as a key to the integrated toxicity risk assessment based primarily on non-animal approaches","volume":"27","author":"Coecke","year":"2013","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.fct.2024.114636_bib26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0531-5565(89)90026-0","article-title":"Doxorubicin toxicity and pharmacokinetics in old and young rats","volume":"24","author":"Colombo","year":"1989","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.fct.2024.114636_bib27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2114\/jpa2.25.113","article-title":"Aging, disability, and frailty: implications for universal design","volume":"25","author":"Crews","year":"2006","journal-title":"J. Physiol. Anthropol."},{"key":"10.1016\/j.fct.2024.114636_bib28","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2165\/00003088-200746070-00002","article-title":"Strategies to improve drug delivery across the blood-brain barrier","volume":"46","author":"de Boer","year":"2007","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.fct.2024.114636_bib29","doi-asserted-by":"crossref","first-page":"F118","DOI":"10.1152\/ajprenal.00110.2008","article-title":"Structural and functional changes in the kidneys of high-fat diet-induced obese mice","volume":"296","author":"Deji","year":"2009","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.fct.2024.114636_bib30","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.2522\/ptj.20080020","article-title":"Epidemiology of diabetes and diabetes-related complications","volume":"88","author":"Deshpande","year":"2008","journal-title":"Phys. Ther."},{"key":"10.1016\/j.fct.2024.114636_bib31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1186\/s12917-022-03518-8","article-title":"Morbidity and mortality in elderly dogs - a model for human aging","volume":"18","author":"Dias-Pereira","year":"2022","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.fct.2024.114636_bib32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jsps.2013.11.002","article-title":"Alternatives to animal testing: a review","volume":"23","author":"Doke","year":"2015","journal-title":"Saudi Pharmaceut. J."},{"key":"10.1016\/j.fct.2024.114636_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008888","article-title":"Trends in prevalence and control of hypertension according to the 2017 American college of cardiology\/American heart association (ACC\/AHA) guideline","volume":"7","author":"Dorans","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.fct.2024.114636_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics9040044","article-title":"Altered protein expression of cardiac CYP2J and hepatic CYP2C, CYP4A, and CYP4F in a mouse model of type II diabetes-A link in the onset and development of cardiovascular disease?","volume":"9","author":"Drolet","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.fct.2024.114636_bib35","article-title":"Development of a roadmap for action on new approach methodologies in risk assessment","year":"2022","journal-title":"EFSA Support Publ. EFSA"},{"key":"10.1016\/j.fct.2024.114636_bib36","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0378-4274(83)90241-2","article-title":"Potentiation of thioacetamide-induced hepatotoxicity in alloxan- and streptozotocin-diabetic rats","volume":"17","author":"El-Hawari","year":"1983","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.fct.2024.114636_bib37","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1006\/bbrc.1999.0202","article-title":"Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob\/ob mice, and fa\/fa Zucker rats","volume":"255","author":"Enriquez","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.fct.2024.114636_bib38","series-title":"New Approach Methodologies in Regulatory Science","year":"2016"},{"key":"10.1016\/j.fct.2024.114636_bib39","series-title":"New Approach Methodologies in Regulatory Science","year":"2016"},{"key":"10.1016\/j.fct.2024.114636_bib40","article-title":"The 2018 ageing report: underlying assumptions and projection methodologies","year":"2017","journal-title":"Institutional Paper, Brussels"},{"key":"10.1016\/j.fct.2024.114636_bib41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/eos.12175","article-title":"Animal research as a basis for clinical trials","volume":"123","author":"Faggion","year":"2015","journal-title":"Eur. J. Oral Sci."},{"key":"10.1016\/j.fct.2024.114636_bib42","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/jbmr.2210","article-title":"A review of rodent models of type 2 diabetic skeletal fragility","volume":"29","author":"Fajardo","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"55\u201370","key":"10.1016\/j.fct.2024.114636_bib43","first-page":"137","article-title":"Effects of disease on expression and regulation of CYPs","volume":"20","author":"Farrell","year":"1999","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.fct.2024.114636_bib44","series-title":"Product Development under the Animal Rule Guidance for Industry","year":"2015"},{"key":"10.1016\/j.fct.2024.114636_bib45","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1042\/CS20160823","article-title":"Kidney, heart and brain: three organs targeted by ageing and glycation","volume":"131","author":"Frimat","year":"2017","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.fct.2024.114636_bib46","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/2327-6924.12510","article-title":"Obesity: risk factors, complications, and strategies for sustainable long-term weight management","volume":"29","author":"Fruh","year":"2017","journal-title":"J Am Assoc Nurse Pract"},{"key":"10.1016\/j.fct.2024.114636_bib47","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1128\/AAC.00907-16","article-title":"Organic cation transporter 2 overexpression may confer an increased risk of gentamicin-induced nephrotoxicity","volume":"60","author":"Gai","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fct.2024.114636_bib48","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(16)31679-8","article-title":"Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.fct.2024.114636_bib49","series-title":"In Vitro Test Systems and Their Limitations","author":"Ghallab","year":"2013"},{"key":"10.1016\/j.fct.2024.114636_bib50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.lfs.2011.05.005","article-title":"Role of high-fat diet in regulation of gene expression of drug metabolizing enzymes and transporters","volume":"89","author":"Ghose","year":"2011","journal-title":"Life Sci."},{"key":"10.1016\/j.fct.2024.114636_bib51","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s00429-020-02101-x","article-title":"Aging impairs perceptual decision-making in mice: integrating computational and neurobiological approaches","volume":"225","author":"Gur","year":"2020","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.fct.2024.114636_bib52","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/bjd.15065","article-title":"Skin absorption through atopic dermatitis skin: a systematic review","volume":"177","author":"Halling-Overgaard","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.fct.2024.114636_bib53","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jep.2010.01.004","article-title":"Prevention of type 2 diabetes induced by high fat diet in the C57BL\/6J mouse by two medicinal plants used in traditional treatment of diabetes in the east of Algeria","volume":"128","author":"Hamza","year":"2010","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.fct.2024.114636_bib54","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/10408440802368642","article-title":"A comparison of rat chronic progressive nephropathy with human renal disease-implications for human risk assessment","volume":"39","author":"Hard","year":"2009","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.fct.2024.114636_bib55","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1017\/S0954422410000168","article-title":"High-fat diet-induced obesity in animal models","volume":"23","author":"Hariri","year":"2010","journal-title":"Nutr. Res. Rev."},{"key":"10.1016\/j.fct.2024.114636_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12986-020-00456-w","article-title":"High fat diet significantly changed the global gene expression profile involved in hepatic drug metabolism and pharmacokinetic system in mice","volume":"17","author":"He","year":"2020","journal-title":"Nutr. Metabol."},{"key":"10.1016\/j.fct.2024.114636_bib57","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0041-008X(85)90284-4","article-title":"Comparison of the severity of the chronic cardiotoxicity produced by doxorubicin in normotensive and hypertensive rats","volume":"78","author":"Herman","year":"1985","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.fct.2024.114636_bib58","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/bmc.1724","article-title":"Rapid determination and comparative pharmacokinetics of tetrahydropalmatine in spontaneously hypertensive rats and normotensive rats","volume":"26","author":"Hong","year":"2012","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.fct.2024.114636_bib59","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/jvp.12163","article-title":"Impact of age on hepatic cytochrome P450 of domestic male Camborough-29 pigs","volume":"38","author":"Hu","year":"2015","journal-title":"J. Vet. Pharmacol. Therapeut."},{"key":"10.1016\/j.fct.2024.114636_bib60","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","article-title":"Principles of early drug discovery","volume":"162","author":"Hughes","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.fct.2024.114636_bib61","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/HJH.0b013e328352b89a","article-title":"Development of structural kidney damage in spontaneously hypertensive rats","volume":"30","author":"Hultstrom","year":"2012","journal-title":"J. Hypertens."},{"key":"10.1016\/j.fct.2024.114636_bib62","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0022-3565(25)39399-7","article-title":"Identification of CYP2C23 expressed in rat kidney as an arachidonic acid epoxygenase","volume":"267","author":"Imaoka","year":"1993","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.fct.2024.114636_bib63","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1358\/mf.2009.31.4.1373958","article-title":"Experimental rodent models of type 2 diabetes: a review","volume":"31","author":"Islam","year":"2009","journal-title":"Methods Find Exp. Clin. Pharmacol."},{"key":"10.1016\/j.fct.2024.114636_bib64","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2174\/157340310793566109","article-title":"The DOCA-salt hypertensive rat as a model of cardiovascular oxidative and inflammatory stress","volume":"6","author":"Iyer","year":"2010","journal-title":"Curr. Cardiol. Rev."},{"key":"10.1016\/j.fct.2024.114636_bib65","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5507\/bp.2010.017","article-title":"Phase II drug metabolizing enzymes","volume":"154","author":"Jancova","year":"2010","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"10.1016\/j.fct.2024.114636_bib66","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10557-014-6510-4","article-title":"Cytochrome P450 1B1 contributes to increased blood pressure and cardiovascular and renal dysfunction in spontaneously hypertensive rats","volume":"28","author":"Jennings","year":"2014","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.fct.2024.114636_bib67","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1080\/13880209.2016.1255649","article-title":"Effects of type 2 diabetes mellitus on the pharmacokinetics of berberine in rats","volume":"55","author":"Jia","year":"2017","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.fct.2024.114636_bib68","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2478\/v10102-011-0018-6","article-title":"Alternative methods in toxicology: pre-validated and validated methods","volume":"4","author":"Kandarova","year":"2011","journal-title":"Interdiscipl. Toxicol."},{"key":"10.1016\/j.fct.2024.114636_bib69","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1179\/102453311X13025568941880","article-title":"Bortezomib in patients with renal impairment","volume":"16","author":"Kaygusuz","year":"2011","journal-title":"Hematology"},{"key":"10.1016\/j.fct.2024.114636_bib70","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bcp.2006.09.006","article-title":"Obesity-induced increase of CYP2E1 activity and its effect on disposition kinetics of chlorzoxazone in Zucker rats","volume":"73","author":"Khemawoot","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.fct.2024.114636_bib71","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.mri.2016.06.002","article-title":"Time-course metabolic changes in high-fat diet-induced obesity rats: a pilot study using hyperpolarized (13)C dynamic MRS","volume":"34","author":"Kim","year":"2016","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.fct.2024.114636_bib72","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1476-5381.2012.01911.x","article-title":"The use of animal models in diabetes research","volume":"166","author":"King","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.fct.2024.114636_bib73","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/bcp.12086","article-title":"Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT)","volume":"76","author":"Knights","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.fct.2024.114636_bib74","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/18723128112066660016","article-title":"Effects of obesity induced by high-fat diet on the pharmacokinetics of atazanavir in rats","volume":"7","author":"Kobuchi","year":"2013","journal-title":"Drug Metabol. Lett."},{"key":"10.1016\/j.fct.2024.114636_bib75","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mad.2016.10.001","article-title":"Mouse models of ageing and their relevance to disease","volume":"160","author":"K\u00f5ks","year":"2016","journal-title":"Mechanisms of ageing and development"},{"key":"10.1016\/j.fct.2024.114636_bib76","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11886-021-01484-5","article-title":"Drug repurposing: claiming the full benefit from drug development","volume":"23","author":"Kort","year":"2021","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.fct.2024.114636_bib77","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3109\/00498254.2014.903532","article-title":"Age-related pharmacokinetic changes of acetaminophen, antipyrine, diazepam, diphenhydramine, and ofloxacin in male cynomolgus monkeys and beagle dogs","volume":"44","author":"Koyanagi","year":"2014","journal-title":"Xenobiotica"},{"key":"10.1016\/j.fct.2024.114636_bib78","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3109\/00498254.2014.979271","article-title":"Age-related changes of hepatic clearances of cytochrome P450 probes, midazolam and R-\/S-warfarin in combination with caffeine, omeprazole and metoprolol in cynomolgus monkeys using in vitro-in vivo correlation","volume":"45","author":"Koyanagi","year":"2015","journal-title":"Xenobiotica"},{"key":"10.1016\/j.fct.2024.114636_bib79","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s12272-014-0452-z","article-title":"Effects of age increase on hepatic expression and activity of cytochrome P450 in male C57BL\/6 mice","volume":"38","author":"Kwak","year":"2015","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.fct.2024.114636_bib80","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1053\/jhep.2001.22754","article-title":"Pseudocapillarization and associated energy limitation in the aged rat liver","volume":"33","author":"Le Couteur","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.fct.2024.114636_bib81","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ijpharm.2017.09.018","article-title":"Physicochemical properties of mucus and their impact on transmucosal drug delivery","volume":"532","author":"Leal","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.fct.2024.114636_bib82","doi-asserted-by":"crossref","first-page":"12063","DOI":"10.1074\/jbc.271.20.12063","article-title":"Role of CYP2E1 in the hepatotoxicity of acetaminophen","volume":"271","author":"Lee","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.fct.2024.114636_bib83","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0378-4274(02)00333-8","article-title":"Role of metabolism by flavin-containing monooxygenase in thioacetamide-induced immunosuppression","volume":"136","author":"Lee","year":"2003","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.fct.2024.114636_bib84","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jaut.2010.09.001","article-title":"Successful modulation of type 2 diabetes in db\/db mice with intra-bone marrow--bone marrow transplantation plus concurrent thymic transplantation","volume":"35","author":"Li","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.fct.2024.114636_bib85","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/171383","article-title":"Age-associated molecular changes in the kidney in aged mice","volume":"2012","author":"Lim","year":"2012","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.fct.2024.114636_bib86","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ccc.2021.03.001","article-title":"Pharmacokinetic and pharmacodynamic principles for toxicology","volume":"37","author":"Lista","year":"2021","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.fct.2024.114636_bib87","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2165\/11319330-000000000-00000","article-title":"Effects of varying degrees of renal impairment on the pharmacokinetics of duloxetine: analysis of a single-dose phase I study and pooled steady-state data from phase II\/III trials","volume":"49","author":"Lobo","year":"2010","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.fct.2024.114636_bib88","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/019262339802600102","article-title":"Xenobiotic metabolizing enzymes of the kidney","volume":"26","author":"Lock","year":"1998","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.fct.2024.114636_bib89","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1472-8206.1998.tb00985.x","article-title":"Cytochrome P450 2E1 activity in diabetic and obese patients as assessed by chlorzoxazone hydroxylation","volume":"12","author":"Lucas","year":"1998","journal-title":"Fund. Clin. Pharmacol."},{"key":"10.1016\/j.fct.2024.114636_bib90","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1023\/A:1006883919687","article-title":"Alterations in susceptibility to carbon tetrachloride toxicity and hepatic antioxidant\/detoxification system in streptozotocin-induced short-term diabetic rats: effects of insulin and Schisandrin B treatment","volume":"175","author":"Mak","year":"1997","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.fct.2024.114636_bib91","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0531-5565(02)00168-7","article-title":"Effect of age and hypoxia\/reoxygenation on mRNA expression of antioxidative enzymes in rat liver and kidneys","volume":"37","author":"Martin","year":"2002","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.fct.2024.114636_bib92","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.semnephrol.2014.02.010","article-title":"The kidney and uremic toxin removal: glomerulus or tubule?","volume":"34","author":"Masereeuw","year":"2014","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.fct.2024.114636_bib93","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics9040040","article-title":"Tissue specific modulation of cyp2c and cyp3a mRNA levels and activities by diet-induced obesity in mice: the impact of type 2 diabetes on drug metabolizing enzymes in liver and extra-hepatic tissues","volume":"9","author":"Maximos","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.fct.2024.114636_bib94","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1021\/tx200211v","article-title":"Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety","volume":"24","author":"Meanwell","year":"2011","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.fct.2024.114636_bib95","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/COC.0b013e318174dbb9","article-title":"Intestinal permeability and vitamin A absorption in patients with chemotherapy-induced diarrhea","volume":"31","author":"Melichar","year":"2008","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.fct.2024.114636_bib96","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/03602532.2011.577781","article-title":"Drug metabolism alterations in nonalcoholic fatty liver disease","volume":"43","author":"Merrell","year":"2011","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.fct.2024.114636_bib97","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1177\/0192623312457273","article-title":"Use of animal models of human disease for nonclinical safety assessment of novel pharmaceuticals","volume":"41","author":"Morgan","year":"2013","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.fct.2024.114636_bib98","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrd.2017.244","article-title":"Impact of a five-dimensional framework on R&D productivity at AstraZeneca","volume":"17","author":"Morgan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.fct.2024.114636_bib99","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ymgme.2014.07.005","article-title":"Nonclinical safety assessment of recombinant human acid sphingomyelinase (rhASM) for the treatment of acid sphingomyelinase deficiency:the utility of animal models of disease in the toxicological evaluation of potential therapeutics","volume":"114","author":"Murray","year":"2015","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.fct.2024.114636_bib100","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejpb.2017.04.026","article-title":"Role of regional absorption and gastrointestinal motility on variability in oral absorption of a model drug","volume":"117","author":"Narang","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.fct.2024.114636_bib101","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.fct.2024.114636_bib102","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1292\/jvms.20-0479","article-title":"Chronic low-dose exposure to imidacloprid potentiates high fat diet-mediated liver steatosis in C57BL\/6J male mice","volume":"83","author":"Nimako","year":"2021","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.fct.2024.114636_bib103","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cbi.2011.12.010","article-title":"Hepatic expression of cytochrome P450 in type 2 diabetic Goto-Kakizaki rats","volume":"195","author":"Oh","year":"2012","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.fct.2024.114636_bib104","article-title":"Hypertension","volume":"4","author":"Oparil","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.fct.2024.114636_bib105","first-page":"282","article-title":"Insulin-induced hypoglycemic peripheral motor neuropathy in spontaneously diabetic WBN\/Kob rats","volume":"60","author":"Ozaki","year":"2010","journal-title":"Comp. Med."},{"key":"10.1016\/j.fct.2024.114636_bib106","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.82","article-title":"Modulation of CYP3a expression and activity in mice models of type 1 and type 2 diabetes","volume":"2","author":"Patoine","year":"2014","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.fct.2024.114636_bib107","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000357524","article-title":"Systematic review focusing on the excretion and protection roles of sweat in the skin","volume":"228","author":"Peng","year":"2014","journal-title":"Dermatology"},{"key":"10.1016\/j.fct.2024.114636_bib108","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/toxres\/tfaa081","article-title":"Justification for species selection for pharmaceutical toxicity studies","volume":"9","author":"Prior","year":"2020","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.fct.2024.114636_bib109","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2125.1995.tb04422.x","article-title":"Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine","volume":"39","author":"Rasmussen","year":"1995","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.fct.2024.114636_bib110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/(SICI)1099-0461(2000)14:3<131::AID-JBT2>3.0.CO;2-Q","article-title":"Modulation of xenobiotic metabolism and oxidative stress in chronic streptozotocin-induced diabetic rats fed with Momordica charantia fruit extract","volume":"14","author":"Raza","year":"2000","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.fct.2024.114636_bib111","article-title":"Race, geographical location and other risk factors for hypertension: South African National Health and Nutrition Examination Survey 2011\/12","volume":"16","author":"Reddy","year":"2021","journal-title":"SSM Popul Health"},{"key":"10.1016\/j.fct.2024.114636_bib112","first-page":"337","article-title":"Factors contributing to variability in drug pharmacokinetics. IV. Renal excretion","volume":"10","author":"Regardh","year":"1985","journal-title":"J. Clin. Hosp. Pharm."},{"key":"10.1016\/j.fct.2024.114636_bib113","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-57002-9","article-title":"Short- and medium-term impact of bariatric surgery on the activities of CYP2D6, CYP3A4, CYP2C9, and CYP1A2 in morbid obesity","volume":"9","author":"Rodriguez-Morato","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.fct.2024.114636_bib114","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1006\/taap.1997.8301","article-title":"Is exposure to bacterial endotoxin a determinant of susceptibility to intoxication from xenobiotic agents?","volume":"147","author":"Roth","year":"1997","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.fct.2024.114636_bib115","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1111\/bph.15621","article-title":"Lung pharmacokinetics of inhaled and systemic drugs: a clinical evaluation","volume":"178","author":"Sadiq","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.fct.2024.114636_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111327","article-title":"Rethinking toxicity testing: influence of aging on the outcome of long-term toxicity testing and possible remediation","volume":"141","author":"Saghir","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.fct.2024.114636_bib117","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1152\/physiolgenomics.00194.2006","article-title":"A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human","volume":"29","author":"Salek","year":"2007","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.fct.2024.114636_bib118","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1472-8206.2004.00299.x","article-title":"Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update","volume":"19","author":"Schachter","year":"2005","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.fct.2024.114636_bib119","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1007\/s00125-011-2069-9","article-title":"The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes","volume":"54","author":"Shimoda","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.fct.2024.114636_bib120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0165-1161(92)90031-G","article-title":"Species differences in the genotoxicity of cyclophosphamide and styrene in three in vivo assays","volume":"271","author":"Simula","year":"1992","journal-title":"Mutat. Res."},{"key":"10.1016\/j.fct.2024.114636_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104757","article-title":"Advances in selecting appropriate non-rodent species for regulatory toxicology research: policy, ethical, and experimental considerations","volume":"116","author":"Son","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.fct.2024.114636_bib122","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17239101","article-title":"Impact of adverse drug reactions in patients with end stage renal disease in Greece","volume":"17","author":"Spanakis","year":"2020","journal-title":"Int. J. Environ. Res. Publ. Health"},{"issue":"Suppl. 1","key":"10.1016\/j.fct.2024.114636_bib123","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1467-789X.2007.00319.x","article-title":"Animal models of obesity","volume":"8","author":"Speakman","year":"2007","journal-title":"Obes. Rev."},{"key":"10.1016\/j.fct.2024.114636_bib124","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1258\/la.2007.006067","article-title":"The contribution of animal models to the study of obesity","volume":"42","author":"Speakman","year":"2008","journal-title":"Lab. Anim."},{"key":"10.1016\/j.fct.2024.114636_bib125","doi-asserted-by":"crossref","first-page":"370","DOI":"10.18632\/aging.100756","article-title":"Interstitial pericytes decrease in aged mouse kidneys","volume":"7","author":"Stefanska","year":"2015","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.fct.2024.114636_bib126","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1677\/jme.1.01679","article-title":"Analysis of gene expression profiles in insulin-sensitive tissues from pre-diabetic and diabetic Zucker diabetic fatty rats","volume":"34","author":"Suh","year":"2005","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.fct.2024.114636_bib127","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/s41419-020-03122-4","article-title":"High-fat diet promotes renal injury by inducing oxidative stress and mitochondrial dysfunction","volume":"11","author":"Sun","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.fct.2024.114636_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.fct.2024.114636_bib129","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1177\/01926233211003498","article-title":"Opinion on the use of animal models in nonclinical safety assessment: pros and cons","volume":"49","author":"Sura","year":"2021","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.fct.2024.114636_bib130","doi-asserted-by":"crossref","DOI":"10.3390\/cells10051238","article-title":"Hypertension and aging affect liver sulfur metabolism in rats","volume":"10","author":"Szlezak","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.fct.2024.114636_bib131","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1081\/DCT-100100130","article-title":"Peripheral neuropathy in B6C3F1 mice and SD rats induced by chronic intermittent insulin hypoglycemia","volume":"23","author":"Tabata","year":"2000","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.fct.2024.114636_bib132","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1248\/bpb.35.192","article-title":"Influence of skin thickness on the in vitro permeabilities of drugs through Sprague-Dawley rat or Yucatan micropig skin","volume":"35","author":"Takeuchi","year":"2012","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.fct.2024.114636_bib133","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.rmed.2011.11.003","article-title":"The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications","volume":"106","author":"Tamimi","year":"2012","journal-title":"Respir. Med."},{"key":"10.1016\/j.fct.2024.114636_bib134","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1023\/A:1018945608888","article-title":"Effect of chronic hypertension on the blood-brain barrier permeability of libenzapril","volume":"9","author":"Tang","year":"1992","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.fct.2024.114636_bib135","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1128\/iai.64.3.769-774.1996","article-title":"Lipopolysaccharide-induced lethality and cytokine production in aged mice","volume":"64","author":"Tateda","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.fct.2024.114636_bib136","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.lfs.2015.04.014","article-title":"Altered cytochrome P450 activities and expression levels in the liver and intestines of the monosodium glutamate-induced mouse model of human obesity","volume":"133","author":"Tomankova","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.fct.2024.114636_bib137","first-page":"600","article-title":"Administration of substances to laboratory animals: routes of administration and factors to consider","volume":"50","author":"Turner","year":"2011","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"10.1016\/j.fct.2024.114636_bib138","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3810\/pgm.2011.09.2475","article-title":"Key concepts of clinical trials: a narrative review","volume":"123","author":"Umscheid","year":"2011","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.fct.2024.114636_bib139","series-title":"Percentage of Population Ages 65 and Olderx","year":"2021"},{"key":"10.1016\/j.fct.2024.114636_bib140","series-title":"Guidance for Industry and Test Method Developers: CPSC Staff Evaluation of Alternative Test Methods and Integrated Testing Approaches and Data Generated from Such Methods to Support FHSA Labeling Requirements","year":"2022"},{"key":"10.1016\/j.fct.2024.114636_bib141","series-title":"Strategic Plan to Promote the Development and Implementation of Alternative Test Methods within the TSCA Program","year":"2018"},{"key":"10.1016\/j.fct.2024.114636_bib142","series-title":"New Approach Methods Work Plan (V2)","year":"2021"},{"key":"10.1016\/j.fct.2024.114636_bib143","series-title":"FDA's Predictive Toxicology Roadmap","year":"2017"},{"key":"10.1016\/j.fct.2024.114636_bib144","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jacbts.2016.03.002","article-title":"Drugs, devices, and the FDA: Part 1: an overview of approval processes for drugs","volume":"1","author":"Van Norman","year":"2016","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.fct.2024.114636_bib145","first-page":"845","article-title":"Limitations of animal studies for predicting toxicity in clinical trials: is it time to rethink our current approach?","volume":"4","author":"Van Norman","year":"2019","journal-title":"JACC (J. Am. Coll. Cardiol.): Basic to Translational Science"},{"key":"10.1016\/j.fct.2024.114636_bib146","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00228-008-0553-z","article-title":"Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction","volume":"64","author":"Verbeeck","year":"2008","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.fct.2024.114636_bib147","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1177\/106002809202601116","article-title":"Contribution of the human kidney to the metabolic clearance of drugs","volume":"26","author":"Vree","year":"1992","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.fct.2024.114636_bib148","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/toxsci\/kfy020","article-title":"Evaluating in vitro-in vivo extrapolation of toxicokinetics","volume":"163","author":"Wambaugh","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.fct.2024.114636_bib149","first-page":"73","article-title":"The impact of early ADME profiling on drug discovery and development strategy","volume":"5","author":"Wang","year":"2004","journal-title":"DDW Drug Discovery World"},{"key":"10.1016\/j.fct.2024.114636_bib150","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2125.2003.01731.x","article-title":"Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans","volume":"55","author":"Wang","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.fct.2024.114636_bib151","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.lfs.2006.06.046","article-title":"Ageing is associated with increased expression but decreased activity of CYP2E1 in male Wistar rats","volume":"79","author":"Wauthier","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.fct.2024.114636_bib152","series-title":"Overweight and Obesity Report Fact Sheet","year":"2020"},{"key":"10.1016\/j.fct.2024.114636_bib153","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pestbp.2019.10.010","article-title":"Effects of imidacloprid, a neonicotinoid insecticide, on the echolocation system of insectivorous bats","volume":"163","author":"Wu","year":"2020","journal-title":"Pestic. Biochem. Physiol."},{"key":"10.1016\/j.fct.2024.114636_bib154","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1124\/dmd.30.8.918","article-title":"Role of constitutive androstane receptor in the in vivo induction of Mrp3 and CYP2B1\/2 by phenobarbital","volume":"30","author":"Xiong","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2024.114636_bib155","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3892\/mmr.2016.5970","article-title":"Age-associated differences in transporter gene expression in kidneys of male rats","volume":"15","author":"Xu","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.fct.2024.114636_bib156","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.7429","article-title":"Age-associated changes of cytochrome P450 and related phase-2 gene\/proteins in livers of rats","volume":"7","author":"Xu","year":"2019","journal-title":"PeerJ"},{"key":"10.1016\/j.fct.2024.114636_bib157","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1590\/S0100-879X2007000500018","article-title":"Sex differences in angiotensin II- induced hypertension","volume":"40","author":"Xue","year":"2007","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.fct.2024.114636_bib158","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/00498254.2013.809616","article-title":"Pharmacokinetics of drugs in spontaneously or secondary hypertensive rats","volume":"44","author":"Yang","year":"2014","journal-title":"Xenobiotica"},{"key":"10.1016\/j.fct.2024.114636_bib159","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1248\/bpb.29.1634","article-title":"Changes in the expression of cytochromes P450 and nuclear receptors in the liver of genetically diabetic db\/db mice","volume":"29","author":"Yoshinari","year":"2006","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.fct.2024.114636_bib160","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1007\/s11095-006-0071-6","article-title":"Hepatic CYP3A expression is attenuated in obese mice fed a high-fat diet","volume":"23","author":"Yoshinari","year":"2006","journal-title":"Pharmaceut. Res."},{"key":"10.1016\/j.fct.2024.114636_bib161","article-title":"High fat diet induces kidney injury via stimulating Wnt\/\u03b2-Catenin signaling","volume":"9","author":"Yu","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.fct.2024.114636_bib162","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ilar.52.1.4","article-title":"Mice as a mammalian model for research on the genetics of aging","volume":"52","author":"Yuan","year":"2011","journal-title":"ILAR J."},{"key":"10.1016\/j.fct.2024.114636_bib163","doi-asserted-by":"crossref","DOI":"10.3390\/biom12111594","article-title":"Serum metabolomic profiling in aging mice using liquid chromatography-mass spectrometry","volume":"12","author":"Yue","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.fct.2024.114636_bib164","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.fct.2012.11.046","article-title":"Hepatic metabolism of sulfur amino acids in db\/db mice","volume":"53","author":"Yun","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.fct.2024.114636_bib165","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2174\/138920006779010575","article-title":"Xenobiotic-metabolizing enzymes in human lung","volume":"7","author":"Zhang","year":"2006","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.fct.2024.114636_bib166","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.bcp.2019.05.002","article-title":"Diet-induced obese alters the expression and function of hepatic drug-metabolizing enzymes and transporters in rats","volume":"164","author":"Zhang","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.fct.2024.114636_bib167","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/01.HYP.0000047877.36743.FA","article-title":"Decreased renal cytochrome P450 2C enzymes and impaired vasodilation are associated with angiotensin salt-sensitive hypertension","volume":"41","author":"Zhao","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.fct.2024.114636_bib168","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/bdd.538","article-title":"Gender difference in the pharmacokinetic interaction between oral warfarin and oxolamine in rats: inhibition of CYP2B1 by oxolamine in male rats","volume":"28","author":"Zhu","year":"2007","journal-title":"Biopharm Drug Dispos."}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691524002023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691524002023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:25:17Z","timestamp":1778682317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691524002023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":168,"alternative-id":["S0278691524002023"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2024.114636","relation":{},"ISSN":["0278-6915"],"issn-type":[{"value":"0278-6915","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential impact of underlying diseases influencing ADME in nonclinical safety assessment","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2024.114636","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114636"}}